People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health?
In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.
Assistant Professor, General Internal Medicine
Boston University School of Medicine
Assistant Professor of Medicine and Pharmacology and Molecular Sciences
Division of Infectious Diseases
Division of Clinical Pharmacology
Johns Hopkins School of Medicine
HIV, ID, and Global Medicine
Zuckerberg San Francisco General Hospital
San Francisco, California
Boston Medical Center
0.5 hour Physicians
0.5 contact hour Nurses
Launch date: March 10, 2020
Expiration date: March 9, 2022